Niryasa Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 06-12-2024
- Revenue 17.26%
(FY 2021)
- Profit 92.97%
(FY 2021)
- Ebitda 80.49%
(FY 2021)
- Net Worth 76.02%
(FY 2021)
- Total Assets 356.62%
(FY 2021)
About Niryasa Life Science
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 Cr.
Savitha Harish and Abhimanyu Harish serve as directors at the Company.
- CIN/LLPIN
U15100KA2019PTC129847
- Company No.
129847
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Chamrajnagar, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Niryasa Life Science?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Savitha Harish | Director | 09-Oct-2020 | Current |
Abhimanyu Harish | Director | 20-Nov-2019 | Current |
Financial Performance of Niryasa Life Science.
Niryasa Life Science Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 17.26% increase. The company also saw a substantial improvement in profitability, with a 92.97% increase in profit. The company's net worth Soared by an impressive increase of 76.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Niryasa Life Science?
In 2021, Niryasa Life Science had a promoter holding of 92.50% and a public holding of 7.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zakinl Infrastructure Private LimitedActive 3 years 1 month
Savitha Harish and Abhimanyu Harish are mutual person
- Zakinl Biotech Private LimitedActive 17 years 3 months
Savitha Harish and Abhimanyu Harish are mutual person
- Zakinl Foods Private LimitedActive 13 years 8 months
Savitha Harish and Abhimanyu Harish are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 30 Jun 2022 | ₹3.00 Cr | Open |
How Many Employees Work at Niryasa Life Science?
Unlock and access historical data on people associated with Niryasa Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Niryasa Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niryasa Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.